Assessment of Primary, Accumulated Dermal Irritability and Health Product Sensitivity by Patch Test _Mklab

Ipclin - Pesquisa Clínica Integrada0 个研究点开始时间: 2019年10月8日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Healthy skin in the region of study (back); Age 18 to 65 years; Gender: male or female; Participants with phototypes I, II, III and IV (according to the Fitzpatrick classification); No history of irritation / allergy to the material used in the study; o Have signed the Informed Consent Form (FICF);
•Participants wishing to participate in the study without financial gain. They will be reimbursed for test-related expenses such as transportation and food.

•Participants who refuse to participate in the study in question.
•Skin tags in the experimental area that interfere with the evaluation of possible skin reactions;
•Active dermatoses (local and widespread) that may interfere with the study results;
•Pregnant or lactating women;
•History of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines;
•o Volunteers with a history of allergy to the material used in the study;
•History of atopy;
•History of conditions aggravated or triggered by ultraviolet radiation;
•carriers of immunodeficiencies;
•Kidney, heart or liver transplantation;
•Intense sun exposure or tanning session up to 15 days prior to initial assessment;
•Prediction of intense sun exposure or tanning session during the study period;
•Prediction of bathing in the sea, pool or sauna during the study;
•Participants who practice water sports;
•Use of the following systemic topical drugs: immunosuppressants, antihistamines, non-hormonal anti-inflammatory drugs, and corticosteroids up to two weeks before selection;
•Treatment with acidic vitamin A and / or its derivatives orally or topically within 1 month before the start of the study;
•Expected vaccination during the study or up to 03 weeks before the study;
•Any condition not mentioned above that, in the opinion of the investigator, may compromise the evaluation of the study.

发起方

Ipclin - Pesquisa Clínica Integrada